1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Early Vedolizumab as First-Line for Immune-Related Colitis Therapy TrialDigestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, intestinal disorderRecruitingPhase 22025-11-04NCT06841705